Compounds Could Be New Class Of Cancer Drugs

News — By on February 4, 2009 at 5:00 am

A team of Vanderbilt University Medical Center investigators has developed a group of chemical compounds that could represent a new class of drugs for treating cancer. The compounds are the first selective inhibitors of the protein phospholipase D (PLD), an enzyme that has been implicated in multiple human cancers including breast, renal, gastric and colorectal.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback